AAAAAA
Results: 1-25/173
Authors:
HOWARD MK
KERSHAW T
GIBB B
STOREY N
MACLEAN AR
ZENG BY
TEL BC
JENNER P
BROWN SM
WOOLF CJ
ANDERSON PN
COFFIN RS
LATCHMAN DS
Citation: Mk. Howard et al., HIGH-EFFICIENCY GENE-TRANSFER TO THE CENTRAL-NERVOUS-SYSTEM OF RODENTS AND PRIMATES USING HERPES-VIRUS VECTORS LACKING FUNCTIONAL ICP27 ANDICP34.5, Gene therapy, 5(8), 1998, pp. 1137-1147
Authors:
KANDA T
TASHIRO T
KUWANA Y
JENNER P
Citation: T. Kanda et al., ADENOSINE A(2A) RECEPTORS MODIFY MOTOR FUNCTION IN MPTP-TREATED COMMON MARMOSETS, NeuroReport, 9(12), 1998, pp. 2857-2860
Authors:
SILVA MT
ROSE S
HINDMARSH JG
JENNER P
MARSDEN CD
Citation: Mt. Silva et al., L-ARGININE PRODUCES NO-INDEPENDENT INCREASES IN DOPAMINE EFFLUX IN RAT STRIATUM, NeuroReport, 9(1), 1998, pp. 149-152
Authors:
SCHERFLER C
WERNING GK
GRANATA R
LABOYRIE PM
QUINN NP
JENNER P
POEWE W
MARSDEN CD
Citation: C. Scherfler et al., A NEURAL TRANSPLANTATION MODEL OF STRIATONIGRAL DEGENERATION, European journal of neuroscience, 10, 1998, pp. 14308-14308
Authors:
RIEDL AG
WATTS PM
JENNER P
MARSDEN CD
Citation: Ag. Riedl et al., P450 ENZYMES AND PARKINSONS-DISEASE - THE STORY SO FAR, Movement disorders, 13(2), 1998, pp. 212-220
Authors:
PEARCE RKB
BANERJI T
JENNER P
MARSDEN CD
Citation: Rkb. Pearce et al., DE-NOVO ADMINISTRATION OF ROPINIROLE AND BROMOCRIPTINE INDUCES LESS DYSKINESIA THAN L-DOPA IN THE MPTP-TREATED MARMOSET, Movement disorders, 13(2), 1998, pp. 234-241
Authors:
JENNER P
Citation: P. Jenner, OXIDATIVE MECHANISMS IN NIGRAL CELL-DEATH IN PARKINSONS-DISEASE, Movement disorders, 13, 1998, pp. 24-34
Authors:
OLANOW CW
JENNER P
BEAL MF
Citation: Cw. Olanow et al., CELL-DEATH AND NEUROPROTECTION IN PARKINSONS-DISEASE - PROCEEDINGS FROM THE SYMPOSIUM - NEUROPROTECTION IN PARKINSONS-DISEASE - OCTOBER 31 NOVEMBER 2, 1997 - CANNES - FOREWORD, Annals of neurology, 44(3), 1998, pp. 5-6
Authors:
JENNER P
OLANOW CW
Citation: P. Jenner et Cw. Olanow, UNDERSTANDING CELL-DEATH IN PARKINSONS-DISEASE, Annals of neurology, 44(3), 1998, pp. 72-84
Authors:
OLANOW CW
JENNER P
BROOKS D
Citation: Cw. Olanow et al., DOPAMINE AGONISTS AND NEUROPROTECTION IN PARKINSONS-DISEASE, Annals of neurology, 44(3), 1998, pp. 167-174
Authors:
KANDA T
JACKSON MJ
SMITH LA
PEARCE RKB
NAKAMURA J
KASE H
KUWANA Y
JENNER P
Citation: T. Kanda et al., ADENOSINE A(2A) ANTAGONIST - A NOVEL ANTIPARKINSONIAN AGENT THAT DOESNOT PROVOKE DYSKINESIA IN PARKINSONIAN MONKEYS, Annals of neurology, 43(4), 1998, pp. 507-513
Authors:
WATTS PM
RIEDL AG
DOUEK DC
EDWARDS RJ
BOOBIS AR
JENNER P
MARSDEN CD
Citation: Pm. Watts et al., COLOCALIZATION OF P450 ENZYMES IN THE RAT SUBSTANTIA-NIGRA WITH TYROSINE-HYDROXYLASE, Neuroscience, 86(2), 1998, pp. 511-519
Authors:
HALLIWELL B
JENNER P
Citation: B. Halliwell et P. Jenner, IMPAIRED CLEARANCE OF OXIDIZED PROTEINS IN NEURODEGENERATIVE DISEASES, Lancet, 351(9114), 1998, pp. 1510-1510
Authors:
TEL BC
ZENG BY
PEARCE RKB
ROSE S
JENNER P
MARSDEN CD
Citation: Bc. Tel et al., CHANGES IN STRIATAL PREPROENKEPHALIN A (PPE-A) AND PREPROTACHYKININ (PPT) MESSENGER-RNA EXPRESSION - THE EFFECTS OF L-DOPA, BROMOCRIPTINE, AND ROPINIROLE IN MPTP-TREATED MARMOSETS, Neurology, 50(4), 1998, pp. 3013-3013
Authors:
MARATOS E
SMITH L
JACKSON MJ
PEARCE RKB
JENNER P
MARSDEN CD
Citation: E. Maratos et al., INDUCING DYSKINESIA IN MPTP-TREATED COMMON MARMOSETS - THE EFFECTS OFREPEATED TREATMENT WITH COMBINATIONS OF L-DOPA AND ROPINIROLE, Neurology, 50(4), 1998, pp. 3014-3014
Authors:
GU M
OWEN AD
TOFFA SEK
COOPER JM
DEXTER DT
JENNER P
MARSDEN CD
SCHAPIRA AHV
Citation: M. Gu et al., MITOCHONDRIAL-FUNCTION, GSH AND IRON IN NEURODEGENERATION AND LEWY BODY DISEASES, Journal of the neurological sciences, 158(1), 1998, pp. 24-29
Authors:
REIST M
MARSHALL KA
JENNER P
HALLIWELL B
Citation: M. Reist et al., TOXIC EFFECTS OF SULFITE IN COMBINATION WITH PEROXYNITRITE ON NEURONAL CELLS, Journal of neurochemistry, 71(6), 1998, pp. 2431-2438
Authors:
SPENCER JPE
JENNER P
DANIEL SE
LEES AJ
MARSDEN DC
HALLIWELL B
Citation: Jpe. Spencer et al., CONJUGATES OF CATECHOLAMINES WITH CYSTEINE AND GSH IN PARKINSONS-DISEASE - POSSIBLE MECHANISMS OF FORMATION INVOLVING REACTIVE OXYGEN SPECIES, Journal of neurochemistry, 71(5), 1998, pp. 2112-2122
Authors:
LYRAS L
PERRY RH
PERRY EK
INCE PG
JENNER A
JENNER P
HALLIWELL B
Citation: L. Lyras et al., OXIDATIVE DAMAGE TO PROTEINS, LIPIDS, AND DNA IN CORTICAL BRAIN-REGIONS FROM PATIENTS WITH DEMENTIA WITH LEWY BODIES, Journal of neurochemistry, 71(1), 1998, pp. 302-312
Authors:
KAUR H
LYRAS L
JENNER P
HALLIWELL B
Citation: H. Kaur et al., ARTIFACTS IN HPLC DETECTION OF 3-NITROTYROSINE IN HUMAN BRAIN-TISSUE, Journal of neurochemistry, 70(5), 1998, pp. 2220-2223
Authors:
SENARATNE RH
MOBASHERI H
PAPAVINASASUNDARAM KG
JENNER P
LEA EA
DRAPER P
Citation: Rh. Senaratne et al., EXPRESSION OF A GENE FOR A PORIN-LIKE PROTEIN OF THE OMPA FAMILY FROMMYCOBACTERIUM-TUBERCULOSIS H37RV, Journal of bacteriology, 180(14), 1998, pp. 3541-3547
Authors:
REIST M
JENNER P
HALLIWELL B
Citation: M. Reist et al., SULFITE ENHANCES PEROXYNITRITE-DEPENDENT ALPHA(1)-ANTIPROTEINASE INACTIVATION - A MECHANISM OF LUNG INJURY BY SULFUR-DIOXIDE, FEBS letters, 423(2), 1998, pp. 231-234
Authors:
ROSE S
HINDMARSH JG
JENNER P
Citation: S. Rose et al., MPP-EVOKED HYDROXYL RADICAL FORMATION IN THE RAT STRIATUM IN-VIVO IS ALTERED BY THE MONOAMINE-OXIDASE INHIBITORS SELEGILINE AND CLORGYLINE,BUT NOT PARGYLINE(), British Journal of Pharmacology, 124, 1998, pp. 7-7
Authors:
GILBERT E
EDWARDS R
SCHULZUTERMOEHL T
BOOBIS A
ROSE S
JENNER P
Citation: E. Gilbert et al., EXPRESSION OF P450 ENZYMES IN PRIMARY RAT VENTRAL MESENCEPHALIC CULTURE, British Journal of Pharmacology, 124, 1998, pp. 40-40
Authors:
IRAVANI MM
BABWAH R
ROSE S
JENNER P
Citation: Mm. Iravani et al., TRANSIENT INDUCTION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IMMUNOREACTIVITY IN NMDA RECEPTOR-MEDIATED NEUROTOXICITY IN THE RAT CAUDATE-PUTAMEN, British Journal of Pharmacology, 124, 1998, pp. 62-62